News

GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart ...
GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication ...
MPR4d
FDA Approves Use of Optison in Pediatric Patients With Suboptimal Echocardiograms
The Food and Drug Administration (FDA) has approved Optison ™ (perflutren protein-type A microsphere) injectable suspension for use in pediatric patients with suboptimal echocardiograms to opacify the ...
Nasdaq3d
GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
GE HealthCare Technologies Inc. GEHC recently announced FDA approval for Optison, its polyethylene glycol (PEG)-free ultrasound enhancing agent, for use in pediatric patients. This milestone ...
Morningstar5d
GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
The latest approval will help provide clearer echocardiogram images for cardiologists to diagnose heart conditions in pediatric patients Optison is the only polyethylene glycol (PEG)-free ...
Nasdaq5d
GE HealthCare Announces FDA Approval For Pediatric Use Of Optison Ultrasound Enhancing Agent
(RTTNews) - GE HealthCare (GEHC) announced Tuesday the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company's Optison (Perflutren Protein-Type A Microspheres ...
Jim Cramer: SoFi Goes To 'New Highs,' Recommends Not Buying This Health Care Stock
The Wall Street veteran's technical analysis of natural gas helped members capture gains on UNG calls. His recent alert ...